Qing H Meng
Overview
Explore the profile of Qing H Meng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
119
Citations
2022
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Zhang Y, Wiencek J, Meng Q, Theel E, Babic N, Sepiashvili L, et al.
Clin Chem
. 2021 Sep;
67(9):1188-1200.
PMID: 34470034
Background: The clinical laboratory continues to play a critical role in managing the coronavirus pandemic. Numerous US Food and Drug Administration emergency use authorization (EUA) and laboratory-developed test (LDT) serologic...
22.
23.
Xu T, Meng Q, Gilchrist S, Lin S, Lin R, Xu T, et al.
Int J Radiat Oncol Biol Phys
. 2021 Jul;
111(4):907-916.
PMID: 34302893
Purpose: Cardiotoxicities induced by cancer therapy can negatively affect quality of life and survival. We investigated whether high-sensitivity cardiac troponin T (hs-cTnT) levels could serve as biomarker for early detection...
24.
Hilaire M, Gill R, Courtney J, Baburina I, Gardiner J, Milone M, et al.
Ther Drug Monit
. 2021 Apr;
43(6):766-771.
PMID: 33814542
Background: Busulfan is an alkylating agent used in allogeneic hematopoietic stem cell transplantation for various malignant and nonmalignant disorders. Therapeutic drug monitoring of busulfan is common because busulfan exposure has...
25.
26.
Zhang X, Zhang R, Chen H, Wang L, Ren C, Pataer A, et al.
Am J Cancer Res
. 2021 Jan;
10(12):4464-4475.
PMID: 33415011
Activating mutations of the KRAS gene are one of the major genomic alterations associated with tumorigenesis of non-small cell lung cancer (NSCLC). Thus far, treatment of KRAS-mutant NSCLC remains an...
27.
Fang B, Meng Q
Crit Rev Clin Lab Sci
. 2020 Jul;
57(6):400-414.
PMID: 32662342
Since Coronavirus Disease 2019 (COVID-19) first emerged in December 2019, the disease has rapidly evolved into a pandemic that threatens societies around the world. As soon as the causative pathogen,...
28.
Knight V, Long T, Meng Q, Linden M, Rhoads D
Arch Pathol Lab Med
. 2020 May;
144(10):1230-1233.
PMID: 32401053
Context.—: The measurement of cytokines in clinical laboratories is becoming an increasingly routine part of immune monitoring when administering biologic and cell-based immunotherapies and also for clinical assessment of inflammatory...
29.
Li J, Chang H, Banchs J, Araujo D, Hassan S, Wagar E, et al.
Cardiooncology
. 2020 Mar;
6:1.
PMID: 32154027
Background: Continuous infusion of doxorubicin or dexrazoxane pre-treatment prior to bolus doxorubicin are proven strategies to protect against doxorubicin-induced cardiotoxicity. Recently, global longitudinal peak systolic strain (GLS) measured with speckle...
30.